Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ERAD Therapeutics

ERAD Therapeutics?uq=AFYHfsyn
2014 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$84.3K LATEST DEAL AMOUNT
Description

Developer of a drug platform designed to create novel biological agents to treat orphan diseases. The company's platform uses an inactive component of a bacterial toxin called the B sub-unit to deliver enzymes and proteins to all cells throughout the body including to brain cells, enabling physicians to treat orphan designated diseases such as Gaucher Disease, Cystic Fibrosis and other lysosomal storage diseases.

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Social/Platform Software
Primary Office
  • 11500 Dahlia Terrace
  • Potomac, MD 20854
  • United States

+1 (703) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ERAD Therapeutics’s full profile, request a free trial.

ERAD Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 09-Nov-2015 $84.3K 000.00 Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

ERAD Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Oscar Bronsther MD Chief Executive Officer & Board Member
George Spitalny Ph.D Chief Scientific Officer & Board Member
Craig Sibley Executive Vice President & Board Member
Robert Bender Chairman

ERAD Therapeutics Board Members (6)

Name Representing Role Since Contact
Info
Brad Thompson Ph.D ERAD Therapeutics Board Member 000 0000
Craig Sibley ERAD Therapeutics Executive Vice President & Board Member 000 0000
George Spitalny Ph.D ERAD Therapeutics Chief Scientific Officer & Board Member 000 0000
Michael Beaubaire MD ERAD Therapeutics Board Member 000 0000
Oscar Bronsther MD ERAD Therapeutics Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »